Outcomes of surgery for infective endocarditis in children: A 30-year experience

J Thorac Cardiovasc Surg. 2019 Nov;158(5):1399-1409. doi: 10.1016/j.jtcvs.2019.06.024. Epub 2019 Jun 20.

Abstract

Background: Infective endocarditis (IE) is rare in children. Limited data have been reported on long-term outcomes of children who undergo surgery for IE.

Methods: Data were retrospectively obtained from medical records for all children who underwent surgery for IE.

Results: Between 1987 and 2017, 138 children with IE required surgery (mean age, 8.3 ± 6.5 years). The majority of children (80.4% [111 out of 138]) had underlying cardiac structural anomalies. Prior heart surgery was performed in 50.7% of patients (70 out of 138), including 19.6% (27 out of 138) who had valve replacement. Operative mortality was 5.8% (8 out of 138). Mean follow-up time was 9.7 ± 7.6 years. Long-term survival at 5 and 25 years was 91.5% (95% confidence interval, 85.1%-95.2%) and 79.1% (95% confidence interval, 66.3%-87.5%), respectively. Risk factors associated with death were: age (hazard ratio [HR], 0.88; P = .015), prosthetic valve IE (HR, 3.86; P = .02), coagulase-negative staphylococci (HR, 4.52; P = .015), increased duration of preoperative antibiotic therapy (HR, 1.02; P = .009), shock (HR, 3.68; P = .028), and aortic valve replacement (HR, 3.22; P = .044). In patients with left-sided IE, risk factors independently associated with death were heart failure (HR, 18.8; P = .025) and vegetation size adjusted to body surface area (HR, 1.06; P = .008). Freedom from recurrent endocarditis was 94.7% (95% confidence interval, 87.7%-97.8%) at 25 years.

Conclusions: Children undergoing surgery for IE had good long-term survival and recurrence of IE was uncommon. Surgery during the active phase of endocarditis did not increase risk of mortality or reoperation. In patients with left-sided IE, vegetation size adjusted for patient body surface area was identified as a risk factor for death, and a useful indicator of prognosis.

Keywords: infective endocarditis; mortality; outcomes; pediatric; reoperation; surgery; timing; valve replacement.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Australia / epidemiology
  • Cardiac Surgical Procedures / adverse effects
  • Cardiac Surgical Procedures / methods
  • Cardiac Surgical Procedures / statistics & numerical data
  • Child
  • Child, Preschool
  • Endocarditis* / diagnosis
  • Endocarditis* / microbiology
  • Endocarditis* / mortality
  • Endocarditis* / surgery
  • Female
  • Heart Defects, Congenital* / complications
  • Heart Defects, Congenital* / epidemiology
  • Heart Valve Diseases* / diagnosis
  • Heart Valve Diseases* / epidemiology
  • Heart Valve Diseases* / surgery
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Heart Valve Prosthesis Implantation* / methods
  • Humans
  • Male
  • Medical Records, Problem-Oriented / statistics & numerical data
  • Prognosis
  • Risk Factors
  • Staphylococcal Infections* / diagnosis
  • Staphylococcal Infections* / therapy
  • Survivors / statistics & numerical data

Substances

  • Anti-Bacterial Agents